Iambic Announces Pricing of Initial Public Offering
Iambic Therapeutics priced its IPO at $16.00 per share, offering 9,375,000 shares for expected gross proceeds of $150.0 million. Underwriters hold a 30-day option on up to 1,406,250 additional shares. The stock begins trading on Nasdaq under ticker IAM on October 15, with closing expected October 16. J.P.
Key figures
- Deal Value Usd
- 150000000
- Offering Price
- 16
- Shares Offered
- 9375000
- Closing date
- 2026-10-16
- Listing date
- 2026-10-15
- Greenshoe days
- 30
- Greenshoe shares
- 1406250
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.